Assyro AI

Orange Book product · Brand (NDA)

OXYCONTIN

OXYCODONE HYDROCHLORIDE

Brand (NDA)NDA 022272RX KNOA PHARMA

At a glance

Apr 05, 2010

Approved

Brand (NDA)

Application

Not listed

TE code

15

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 05, 2010

    16 yr 5 mo ago

  2. Today

  3. Patent 11304908 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  4. Patent 11304909 expires

    Listed method-of-use patent (U-1556) expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  5. Patent 11964056 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  6. Patent 12246094 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  7. Patent 12280152 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  8. Patent 8808741 expires

    Listed method-of-use patent (U-1556) expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  9. Patent 8894988 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  10. Patent 9492389 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  11. Patent 9492391 expires

    Listed method-of-use patent (U-1556) expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  12. Patent 9492392 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  13. Patent 9492393 expires

    Listed method-of-use patent (U-1556) expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  14. Patent 9763933 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  15. Patent 9770416 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  16. Patent 9775808 expires

    Listed drug product patent expiration.

    Aug 24, 2027

    in 1 yr 2 mo

  17. Patent 8894987 expires

    Listed drug product patent expiration.

    Mar 29, 2030

    in 3 yr 10 mo

Pharmaceutical detail

Active ingredient

OXYCODONE HYDROCHLORIDE

Strength

10MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 022272

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (15)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11304908Aug 24, 2027in 1 yr 2 mo
Product
11304909Aug 24, 2027in 1 yr 2 mo
U-1556
11964056Aug 24, 2027in 1 yr 2 mo
Product
12246094Aug 24, 2027in 1 yr 2 mo
Product
12280152Aug 24, 2027in 1 yr 2 mo
Product
8808741Aug 24, 2027in 1 yr 2 mo
U-1556
8894988Aug 24, 2027in 1 yr 2 mo
Product
9492389Aug 24, 2027in 1 yr 2 mo
Product
9492391Aug 24, 2027in 1 yr 2 mo
U-1556
9492392Aug 24, 2027in 1 yr 2 mo
Product
9492393Aug 24, 2027in 1 yr 2 mo
U-1556
9763933Aug 24, 2027in 1 yr 2 mo
Product
9770416Aug 24, 2027in 1 yr 2 mo
Product
9775808Aug 24, 2027in 1 yr 2 mo
Product
8894987Mar 29, 2030in 3 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.